Abstract: The present disclosure relates to a bio-material composition comprising a dry potassium phosphate based mixture omprising: MgO, monobasic potassium phosphate, monobasic sodium phosphate, proteoglycans, calcium sodium phosphosilicate, and an antibiotic, wherein a weight percent ratio of monobasic potassium phosphate to MgO is between about 3:1 and 1:1, wherein the dry otassium phosphate based mixture is configured to be mixed with the aqueous solution to thereby form a reabsorbable bio-material slurry, wherein the proteoglycans are between about 1-10 weight percent of the dry composition, and wherein the proteoglycans act as active regulators of collagen fibrillogenesis to thereby structure tissue of a patient by organizing a bone extracellular matrix.

Abstract: The present disclosure provides a bio-material composition and method of use in craniomaxillofacial surgery. An example method comprises: accessing a space defined between adjacent bone structures in a head of a patient; mixing magnesia, potassium biphosphate, and a calcium phosphate with an aqueous solution to form an activated bone fusion slurry (ABFS); applying an effective amount of the ABFS to the space between the adjacent bone structures; allowing the ABFS to set forming a bonded bone structure; and permitting bone growth into the bonded bone structure providing fusion of the two adjacent bone structures, wherein the ABFS promotes fusion of the two adjacent bone structures without the need for additional physical fixation devices.

Abstract: The present disclosure relates to a device including an elongated hollow shaft having a proximal end and a distal end. The device also includes a first attachment mechanism coupled to the proximal end of the elongated hollow shaft. The device also includes a rod having a proximal end and a distal end. The rod is removably positioned at least partially within a lumen of the elongated hollow shaft. The device also includes a second attachment mechanism coupled to the rod between the proximal end of the rod and the distal end of the rod. The first attachment mechanism and the second attachment mechanism are configured to be removably coupled to one another. The device also includes a cap configured to be removably coupled to the second attachment mechanism.

Abstract: The present disclosure relates to a spinal implant for insertion between two adjacent vertebrae. The spinal implant includes a frame sized to be inserted between the two adjacent vertebrae. The spinal implant also includes a lattice structure disposed at least partially within the frame and exposed on at least one side of the frame to permit bone growth into the lattice structure. The lattice structure comprises a magnesium phosphate material.

Abstract: The present disclosure relates to an orthopedic instrument. The orthopedic instrument includes an elongated hollow shaft having a proximal end and a distal end. The orthopedic instrument also includes a rod having a proximal end and a distal end. The rod is positioned at least partially within a lumen of the elongated hollow shaft. The orthopedic instrument also includes a cutting head having a proximal end and a distal end, wherein the proximal end of the cutting head is coupled to the distal end of the rod. The cutting head is rotatably coupled to the distal end of the elongated hollow shaft between the proximal end of the cutting head and the distal end of the cutting head. A movement of the rod within the lumen of the elongated hollow shaft in a distal direction causes cutting head to transition from a straight configuration to an angled configuration.

Abstract: The present disclosure provides bio-material composition, comprising a dry potassium phosphate based mixture comprising: MgO, monobasic potassium phosphate, monobasic sodium phosphate, proteoglycans, calcium sodium phosphosilicate, and a plurality of spherically-shaped polymers, wherein a weight percent ratio of monobasic potassium phosphate to MgO is between about 3:1 and 1:1, wherein the dry potassium phosphate based mixture is configured to be mixed with the aqueous solution to thereby form a reabsorbable bio-material slurry, wherein the spherically-shaped polymers are between about 1-5 weight percent of the dry composition, and wherein the spherically-shaped polymers are absorbed faster than the remaining components of the reabsorbable bio-material slurry to thereby form pockets within the bio-material composition that enhance reabsorption of the bio-material composition.

Abstract: The present disclosure relates to a method for treating a bone defect using a bio-material with increased porosity and reabsorption characteristics, the method comprising: (a) mixing a dry potassium phosphate based mixture with an aqueous solution to form a reabsorbable bio-material slurry, wherein the dry potassium phosphate based mixture comprises MgO, monobasic potassium phosphate, monobasic sodium phosphate, proteoglycans, and calcium sodium phosphosilicate, wherein a weight percent ratio of monobasic potassium phosphate to MgO is between about 3:1 and 1:1, wherein the dry potassium phosphate based mixture is configured to be mixed with the aqueous solution to thereby form a reabsorbable bio-material slurry, wherein the proteoglycans are between about 1-10 weight percent of the dry composition, (b) accessing a void of a bone defect within a bone, and (c) filling the void with the reabsorbable bio-material slurry, wherein the reabsorbable bio-material slurry is osteoconductive and osteoinductive, thereby e

Abstract: The present disclosure provides a bone-implantable device and methods of use. The bone-implantable device comprises a body having an exterior surface, wherein a portion of the exterior surface includes a cured osteostimulative material comprising MgO.

Abstract: The present disclosure provides a bone-implantable device and methods of use. The bone-implantable device comprises a body having an exterior surface, wherein a portion of the exterior surface includes a cured osteostimulative material comprising MgO.

Abstract: The present disclosure provides a bone-implantable device and methods of use. The bone-implantable device comprises a body having an exterior surface, wherein a portion of the exterior surface includes a cured osteostimulative material comprising MgO.

Abstract: The present disclosure provides a bioabsorbable composite screw and methods of use. The bioabsorbable composite screw includes an elongated body having a proximal end and a distal end. The elongated body includes an outer surface provided with a plurality of threads defined by a plurality of crests and a plurality of roots. The bioabsorbable composite screw also includes a drive socket positioned at the proximal end of the elongated body. The bioabsorbable composite screw including both the elongated body and the drive socket is made from a polymer including poly-lactic acid and either magnesium phosphate or potassium phosphate.

Abstract: The present invention relates to a bio-material composition comprising: a dry potassium phosphate based mixture comprising (a) MgO, monobasic potassium phosphate, monobasic sodium phosphate, a reabsorbing agent, and a tertiary calcium phosphate, wherein the weight percent ratio of monobasic potassium phosphate to metal oxide is between about 3:1 and 1:1; and (b) an aqueous solution, wherein the dry potassium phosphate based mixture is mixed with the aqueous solution forming a reabsorbable bio-material slurry, wherein the reabsorbing agent is between about 1-10 weight percent of the dry composition, and wherein the reabsorbing agent is selected from the group consisting of a sugar compound, hydroxypropyl methyl cellulose (HPMC), carboxymethylcellulose (CMC), a poloxamer, and combinations thereof.

Abstract: The present invention relates to a material and method for promoting motion preservation in a bone. One preferred method comprises (a) accessing an interior of the bone, (a) mixing magnesia, potassium biphosphate, and a calcium phosphate with an aqueous solution forming an activated slurry, (c) applying an effective amount of the activated slurry to the interior of the bone, (d) allowing the activated slurry to set forming a bonded bone structure, and (e) permitting bone growth into the bonded bone structure to thereby promote motion preservation of the bone.

Abstract: The present disclosure provides a bone-implantable device and methods of use. The bone-implantable device comprises a body having an exterior surface, wherein a portion of the exterior surface includes a cured osteostimulative material comprising MgO.